Accordingly, a similar effect of ATOX1 downregulation has been recently reported in DLBCL cells, whereas copper supplementation in ATOX-knockout cells was sufficient to restore ERK1/2 activity [74]. This evidence concerns the gene ATOX1 and diffuse large B-cell lymphoma.